Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-001215
Filing Date
2025-02-13
Accepted
2025-02-13 12:22:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5022
  Complete submission text file 0001085146-25-001215.txt   6695
Mailing Address 599 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE NEW YORK NY 10022 6465621000
Cowen Financial Products LLC (Filed by) CIK: 0001771015 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91774 | Film No.: 25618582
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)